4
Changes in Ownership
Cigna Group Filed Acc 0001225208-24-003131
Chairman & CEO sold 18,772 shares at an average $345.48 ($6,485,320)
- Chairman & CEO acquired 18,772 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cordani David Chairman & CEO | 2024-02-23 | Option exercise 10b5-1 | +6,319 | $139.22 | $879,731 | 343,102 | D |
| Cordani David Chairman & CEO | 2024-02-23 | Sale 10b5-1 | −6,319 | $345.24 | $2,181,592 | 336,783 | D |
| Cordani David Chairman & CEO | 2024-02-26 | Option exercise 10b5-1 | +10,453 | $139.22 | $1,455,267 | 347,236 | D |
| Cordani David Chairman & CEO | 2024-02-26 | Sale 10b5-1 | −100 | $347.14 | $34,714 | 347,136 | D |
| Cordani David Chairman & CEO | 2024-02-26 | Sale 10b5-1 | −3,524 | $346.38 | $1,220,641 | 343,612 | D |
| Cordani David Chairman & CEO | 2024-02-26 | Sale 10b5-1 | −6,829 | $345.34 | $2,358,298 | 336,783 | D |
| Cordani David Chairman & CEO | 2024-02-27 | Option exercise 10b5-1 | +2,000 | $139.22 | $278,440 | 338,783 | D |
| Cordani David Chairman & CEO | 2024-02-27 | Sale 10b5-1 | −2,000 | $345.04 | $690,075 | 336,783 | D |
| Derivatives | |||||||
| Cordani David Chairman & CEO | 2024-02-23 | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −6,319 | 88,882 | D | ||
| Cordani David Chairman & CEO | 2024-02-26 | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −10,453 | 78,429 | D | ||
| Cordani David Chairman & CEO | 2024-02-27 | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −2,000 | 76,429 | D | ||
| Open-market sales · 18,772 sh · avg $345.48 · $6,485,320 | |||||||
Loading xslF345X05/doc4.xml…